Eli Lilly and Co (XTER:LLY) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:LLY Eli Lilly and Co XTER:LLY
87 GF Score
Price €1,036.60
GF Value €1,256.35
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eli Lilly and Co Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

XTER:LLY
87GF Score
Eli Lilly and Co XTER:LLY
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eli Lilly and Co (XTER:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of €1,036.60 is trading 17.5% below its estimated GF Value™ of €1,256.35. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for XTER:LLY:

  • Interest Received:
  • GF Value™: €1,256.35 vs. price of €1,036.60 (17.5% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the XTER:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
87GF Score

Get the complete analysis for XTER:LLY

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1,036.60
Price
€1,256.35
GF Value